Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bridging The Drug Price Divide: Ideas And Approaches Debated At PSA

Executive Summary

Leaders from across the industry met at Informa's Pharmaceutical Strategy conference and addressed some of the most critical issues facing the industry: pharma's tarnished reputation and drug pricing.


Related Content

US Drug Spending: Where Does All The Money Go?
Drug Pricing ‘Biggest Offenders’ Are Annual Increases On Widely Used Brands
Pharma CEOs Tackle A Tough Question: “Why Don’t People Like You?”
Pfizer’s Read Criticizes Rebates Amid Changing Market Dynamics
Merck/Aetna Pact Links Januvia Value-Based Payment To Treatment Intensification
DTC Advertising Is Back With A Bang
Allergan's Price Reform Pledge: Will Others Follow?
More Than 'That Old Shkreli Co.,' KaloBios Ready To Innovate, Change Biotech
KaloBios Pledges To Do The Right Thing On Drug Pricing


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts